We love hearing from our readers. For the fastest response, kindly contact us via email at desinfo411@gmail.com, instead of requesting a response from us via the “comments section” under items.
Thank you!
DES Breast Cancer Cases Update
15 MayJudge Bowler has ordered the parties to attend a mediation session on June 28, 2013 at 10:00 am. With the Motion for Expedited, Consolidated Trial still pending, the Defendants are expected to return in June with a final response to the Court’s guidance to mediate the DES breast cancer cases in good faith.
In the District of Columbia Superior Court, a trial date has been set on January 21, 2014 for the DES breast cancer case of Litterilla v. Eli Lilly and Klein-Connolly v. Eli Lilly. A Frye motion, which challenges the scientific validity of the Plaintiffs’ expert opinions and methodology, is anticipated to be filed by Defendant Eli Lilly and Bristol-Myers Squibb on July 10, 2013.
You Ruined Many “Mother’s Day” with DES, Eli Lilly. Apologize! @LillyPad @wsj
12 MayMother’s Day is always a difficult day for many DES Mothers and Daughters — and Eli Lilly is to blame for that.
It is time for Eli Lilly to do the following:
1. Make a formal apology for the DES drug disaster.
2. Follow through on their (good-faith) promise to settle the remaining cancer cases of DES Daughters who have suffered from breast cancer as a result of DES exposure.
3. Conduct an ongoing public campaign in an effort to reach out to women and men exposed to DES so they can be proactive in advocating for their future health.
4. Similar to the book Eli Lilly published years ago to educate physicians on the “benefits” of prescribing DES to their patients, the Company now needs to publish a book to educate physicians on the side effects associated with being exposed to DES in order to properly care for their DES exposed patients.
Send the tweet below to media and breast cancer influencers ASAP (Twitter addresses listed below, under the two messages):
#EliLilly ruined Mother’s Day for millions but refuses to admit DES breast cancer link. We need #AnswersThatMatter @LillyPad!
Twitter addresses to tweet ASAP:
- WBZ Boston News: @cbsboston
- WCVB-TV Boston: @wcvb
- WHDH Assignment Desk: @deskon7
- Fox 25 News Boston: @fox25news
- Good Morning America: @gma
- The TODAY Show: @thetodayshow
- CBS This Morning: @cbsthismorning
- The View: @theviewtv
- Anderson Cooper 360: @ac360
- The O’Reilly Factor: @oreillyfactor
- ABC Worlds News: @abcworldnews
- CBS Evening News: @cbseveningnews
- NBC Nightly News: @nbcnightlynews
- Top breast cancer influencers’ Twitter addresses are located under their pictures at this link, on the lefthand side of each webpage:http://www.sharecare.com/static/sharecarenow-breast-cancer-top-ten
@WSJ Plz Cover #DES Shame in @lillypad Annual Report #Lilly #LLY #keepLillyhonest
30 MarFrom Pgs 79-80 – Note DES Info has put important quotes in BOLD.
United States Securities and Exchange Commission, Washington, D.C. 20549
Form 10-K Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2012
Commission file number 001-06351
Eli Lilly and Company
Note 15: Contingencies
We are a party to various legal actions and government investigations. The most significant of these are described below. It is not possible to determine the outcome of these matters, and we cannot reasonably estimate the maximum potential exposure or the range of possible loss in excess of amounts accrued for any of these matters; however, we believe that, except as specifically noted below with respect to the Alimta Hatch-Waxman Act patent challenges, the resolution of all such matters will not have a material adverse effect on our consolidated financial position or liquidity, but could possibly be material to our consolidated results of operations in any one accounting period.
Diethylstilbestrol Product Liability Litigation
In approximately 90 U.S. lawsuits against us involving approximately 90 claimants, plaintiffs seek to recover damages on behalf of children or grandchildren of women who were prescribed diethylstilbestrol (DES) during pregnancy in the 1950s and 1960s. Approximately 80 of these claimants allege that they were indirectly exposed in utero to the medicine and later developed breast cancer as a consequence. We believe these claims are without merit and are prepared to defend against them vigorously.
Product Liability Insurance
Because of the nature of pharmaceutical products, it is possible that we could become subject to large numbers of product liability and related claims in the future. In the past several years, we have been unable to obtain product liability insurance due to a very restrictive insurance market. Therefore, for substantially all of our currently marketed products, we have been and expect that we will continue to be completely self-insured for product liability losses. The DES claims are covered by insurance, subject to deductibles and coverage limits. There is no assurance that we will be able to fully collect from our insurance carriers in the future.
DES In Today’s Huffington Post!
13 MarTerrific piece in today’s Huffington Post that ties DES to the World Health Organization’s recent “global threat” announcement about hormone-mimicking chemicals:
Latest Clarifications
11 MarAs you all know, DES Info strives to get you info as soon as possible. Sometimes the info we receive from our sources is a little “off” — but at least we’re trying to share news with you. It beats silence every time.
Below are two clarifications about today’s hearing:
* Aaron Levine, lead attorney for the plaintiffs, and Julie Oliver-Zhang made the motion for the trial to take place on June 25. We will know next week whether that motion has been granted.
* The trial will take place in Boston before Judge Bowler.
Thank you!
Motion for Trial on June 25! #KeepLillyHonest
11 MarEli Lilly refused to mediate. Aaron Levine, lead attorney for the plaintiffs, and Julie Oliver-Zhang moved for expedited trial for 4 women from New York. If the motion is granted, the trial will take place before Judge Bowler on June 25 in Boston.
